The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarray analysis

Journal of Alzheimer's Disease

Volumn 9, Issue 4, 2006, Pages 415-419

  Cavallaro, Rosaria A ^a   Fuso, Andrea ^a   D'Anselmi, Fabrizio ^a   Seminara, Laura ^a   Scarpa, Sigfrido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; DNA methylation; Gene expression; Homocysteine; S adenosylmethionine

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HOMOCYSTEINE; PRESENILIN 1; S ADENOSYLMETHIONINE;

ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; DNA METHYLATION; DNA MICROARRAY; DNA PROBE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; METABOLISM; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 33747386882     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9407     Document Type: Article

References (31)

1. , S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D'Agostino, P.W. Wilson and P.A. Wolf, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N. Engl. J. Med. 346 (2002), 476-483.
2. W. Herrmann, The importance of Hyperhomocysteinemia as a risk factor for diseases: an overview, Clin. Chem. Lab. Med 39(8) (2001), 666-674.
3. E. Joosten, Homocysteine, vascular dementia and Alzheimer's disease, Clin. Chem. Lab. Med. 39(8) (2001), 717-720.
4. K. Beyer, J.L. Lao, P. Latorre, N. Riutort, B. Matute, M.T. Fernandez-Figueras, J.L. Mate and A. Ariza, Methionine synthase polymorphism is a risk factor for Alzheimer disease, Neuroreport 14 (2003), 1391-1394.
5. T. Bottiglieri and K. Hyland, S-adenosylmethionine levels in psychiatric and neurological disorders: a review, Acta Neurol. Scand. Suppl. 154 (1994), 19-26.
6. M.S. Morris, Homocysteine and Alzheimer's disease, Lancet Neurol. 2 (2003), 425-428.
7. L.D. Morrison, D.D. Smith and S.J. Kish, Brain S-adenosylmethionine are severely decreased in Alzheimer's disease, J. Neurochem. 67 (1996), 1328-1331.
8. E.H. Mizrahi, D.W. Jacobsen, S.M. Debanne, F. Traore, A.J. Lerner, R.P. Friedland and G.J. Petot, Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healty aging, J. Nutr. Health Aging 7 (2003), 160-165.
9. S.C. Lu, S-adenosylmethionine, Int. J. Biochem. Cell Biol. 32 (2000), 391-395.
10. M. Fontecave, M. Atta and E. Mulliez, S-adenosylmethionine: nothing goes to waste, TRENDS in Biochemical Sciences 29(5) (2004), 243-249.
11. M.A. Medina, J.L. Urdiales and M.I. Amores-Sanchez, Role of homocysteine in cell metabolism, Eur. J. Biochem. 268 (2001), 3871-3882.
12. J.D. Finkelstein and J.J. Martin, Homocysteine, Int. J. Bioch. Cell. Biol. 32 (2000), 385-389.
13. S.E.S. Miner, J. Evrovski and D.E.C. Cole, Clinical chemistry and molecular biology of homocysteine metabolism: an update, Clinical Biochemistry 30(3) (1997), 189-201.
14. J.M. Mato, F.J. Corrales, S.C. Lu and M.A. Avila, S-adenosylmethionine: a control switch that regulates liver function, FASEB J. 16 (2002), 15-26.
15. P.K. Chiang, R.K. Gordon, J. Tal, G.C. Zeng, B.P. Doctor, K. Pardhasaradhi and P.P. McCann, S-adenosylmethionine and methylation, FASEB J. 10 (1996), 471-480.
16. M. Ohno, E.A. Sametsky, L.H. Younkin, H. Oakley, S.G. Younkin, M. Citron, R. Vassar and J.F. Disterhoft, BACE 1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease, Neuron 41 (2004), 27-33.
17. D.J. Selkoe, Presenilin, Notch and the genesis and treatment of Alzheimer's disease, Proc. Nat. Acad. Sci. USA. 98 (2001), 11039-11041.
18. B. De Strooper, Alzheimer disease. Closing in on gamma secretase, Nature 405 (2000), 627-629.
19. A. Fuso, R.A. Cavallaro, L. Orru, F.R. Buttarelli and S. Scarpa, Gene silencing by S-adenosylmethionine in muscle differentiation, FEBS Lett. 508 (2001), 337-340.
20. S. Scarpa, A. Fuso, F. D'Anselmi and R.A. Cavallaro, Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer's disease? FEBS Lett. 541 (2003), 145-148.
21. A. Fuso, L. Seminara, R.A. Cavallaro, F. D'Anselmi and S. Scarpa, S-adensoylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production, Mol. Cell. Neurosci. 28 (2005), 195-204.
22. B. Richardson, DNA methylation and autoimmune disease, Clin. Immunol. 109 (2003), 72-79.
23. A. Razin, CpG methylation, chromatin structure and gene silencing - a three way connection, EMBO J. 17 (1998), 4905-4908.
24. Y. Bergman and R. Mostoslavsky, DNA demethylation: turning genes on, Biol. Chem. 379 (1998), 401-407.
25. A.M. Mathieu-Kia, L.Q. Fan, M.J. Kreek, E.J. Simon and J.M. Hiller, Mu-. Delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients, Brain. Res. 893 (2001), 121-134.
26. E.B. De Souza, Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders, Psychoneuroendocrinology 20(8) (1995), 789-819.
27. A.M. Hussain and A.K. Mitra, Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level, Drug Metab. Dispos. 28 (200), 1038-1042.
28. A.P. Ducruet, A. Vogt, P. Wipf and J.S. Lazo, Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease, Annu. Rev. Pharmacol. Toxicol. 45 (2005), 725-750.
29. E. Angulo, V. Noe, V. Casado, J. Mallol, T. Gomez-Isla, C. Lluis, I. Ferrer, C.J. Ciudad and R. Franco, Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease, J. Neurochem. 91(3) (2004), 547-557.
30. S.K. Smith, H.A Anderson, G. Yu, A.G. Robertson, S.J. Allen, S.J. Tyler, R.L. Naylor, G. Mason, G.W. Wilcock, P.A. Roche, P.E. Eraser and D. Dawbarn, Identification of syntaxin 1A as a novel binding protein for presenilin-1, Brain Res. Mol. Brain Res. 78(1-2) (2000), 100-107.
31. Q. Lian, C.J. Ladner, D. Magnuson and J.M. Lee, Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex, Exper. Neurol. 167 (2001), 158-165.